GlassScriptPhysician profile
Aaron B Hoffman
NPI 1124248190
$184,980.61
in general payments reported to CMS, 2019-2025
19 companies · $2,372 in 2025
The $2,372 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $9,774 · 2021: $15K · 2022: $80K · 2023: $45K · 2024: $95.56 · 2025: $2,372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Travel and Lodging: $5,869 · Consulting Fee: $4,800 · Acquisitions: $2,705 · Food and Beverage: $1,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,000.00 |
| Travel and Lodging | $5,868.94 |
| Consulting Fee | $4,800.00 |
| Acquisitions | $2,704.70 |
| Food and Beverage | $1,440.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Standard Bariatrics, INC. | $128,678.77 | 2019-2023 | Titan Sgs Standard Gastric Stapler |
| Teleflex LLC | $46,272.20 | 2023-2025 | Titan Sgs Standard Gastric Stapler, Titan Sgs Bailout Chuck |
| Asensus Surgical, INC. | $5,600.00 | 2019 | |
| Ethicon INC. | $2,260.00 | 2019-2020 | |
| Teleflex Medical Incorporated | $746.09 | 2022-2023 | Titan Sgs Standard Gastric Stapler |
| Intuitive Surgical, INC. | $431.48 | 2019-2025 | |
| Ethicon US, LLC | $265.24 | 2019-2024 | Echelon; Endopath, Echelon Flex |
| Activ Surgical, INC. | $143.95 | 2022 | |
| Conmed Corporation | $117.49 | 2021 | |
| Medtronic, INC. | $105.75 | 2022-2025 | Signia, Ligasure |
| Stryker Corporation | $96.14 | 2021 | |
| Tela Bio, INC. | $66.90 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Gt Metabolic Solutions INC | $58.77 | 2025 | |
| Octapharma USA, INC. | $50.96 | 2025 | Fibryga |
| Abbvie INC. | $27.84 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $22.72 | 2023 | Renasys Go V2 Home, Pico, Renasys Touch |
| Urgo Medical North America, LLC | $19.40 | 2023 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Polynovo North America LLC | $16.91 | 2025 | Novosorb Btm |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$18,068.06 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.